Endoscopy 2020; 52(12): v48
DOI: 10.1055/a-1199-8799
Author commentary

Author commentary on Yuhang Zhang et al.

› Further Information
Also available at
 
  Permissions and Reprints

    Yuhang Zhang et al. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial

    This small randomized controlled trial showed that adjunctive radiotherapy following endoscopic submucosal dissection of T1a esophageal squamous cell carcinoma improved 3-year recurrence-free survival (100 % vs. 85.3 %; P = 0.04).

    Quality:

    #

    Publication History

    Article published online:
    25 November 2020

    © 2020. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany

    Refers to:

    Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled TrialEndoscopy 2020; 52(12): 1066-1074
    DOI: 10.1055/a-1198-5232

        Permissions and Reprints